| Date | Time | Source | Headline | Symbol | Company |
| 06/03/2013 | 21:57 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 14/02/2013 | 20:57 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 07/02/2013 | 21:29 | Edgar (US Regulatory) | Proxy Statement - Merger or Acquistion (definitive) (defm14a) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 05/02/2013 | 22:12 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 05/02/2013 | 22:10 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 05/02/2013 | 22:10 | Edgar (US Regulatory) | Definitive Materials Filed by Investment Companies. (497) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 05/02/2013 | 21:30 | GlobeNewswire Inc. | Somaxon Pharmaceuticals Announces Settlement of Silenor Patent Litigation With Actavis | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 04/02/2013 | 21:41 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 04/02/2013 | 21:32 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 01/02/2013 | 22:06 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 01/02/2013 | 22:04 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 28/01/2013 | 17:21 | Zacks | PTX Reduces Sales Force, CFO Quits - Analyst Blog | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 18/01/2013 | 21:23 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 04/01/2013 | 18:15 | Zacks | Pernix Acquires Cypress and Hawthorn - Analyst Blog | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 04/01/2013 | 00:02 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 04/01/2013 | 00:01 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 03/01/2013 | 23:55 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 03/01/2013 | 23:55 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 03/01/2013 | 23:54 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 03/01/2013 | 23:54 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 03/01/2013 | 23:52 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 03/01/2013 | 23:52 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 03/01/2013 | 23:51 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 03/01/2013 | 23:51 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 03/01/2013 | 23:47 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 03/01/2013 | 23:47 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 03/01/2013 | 23:46 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 03/01/2013 | 23:46 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 03/01/2013 | 23:46 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |
| 03/01/2013 | 23:46 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SOMX | Somaxon Pharmaceuticals, Inc. (MM) |